Postoperative survival following perioperative MAGIC versus neoadjuvant OE02-type chemotherapy in oesophageal adenocarcinoma

The optimal management of resectable oesophageal adenocarcinoma is controversial, with many centres using neoadjuvant chemotherapy following the Medical Research Council (MRC) oesophageal working group (OE02) trial and the MRC Adjuvant Gastric Infusional Chemotherapy (MAGIC) trial. The more intensiv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann R Coll Surg Engl
Main Authors: Reece-Smith, AM, Saunders, JH, Soomro, IN, Bowman, CR, Duffy, JP, Kaye, PV, Welch, NT, Madhusudan, S, Parsons, SL
Formato: Artigo
Idioma:Inglês
Publicado: Royal College of Surgeons 2017
Assuntos:
Paediatric Surgery
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5449699/
https://ncbi.nlm.nih.gov/pubmed/28462649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1308/rcsann.2017.0024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares